Difference between revisions of "Leadership"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 13: Line 13:
 
  Greg Corboy, PhD
 
  Greg Corboy, PhD
 
  LabPlus Auckland City Hospital (Auckland, New Zealand)
 
  LabPlus Auckland City Hospital (Auckland, New Zealand)
  School of Clinical Sciences Monash University (Melbourne, Australia)
+
  School of Clinical Sciences, Monash University (Melbourne, Australia)
 
  Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia)
 
  Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia)
 
  '''Co-Associate Editor CCGA [Lymphoma Section]'''
 
  '''Co-Associate Editor CCGA [Lymphoma Section]'''

Revision as of 14:10, 14 May 2020

Meet your editors! We welcome questions and your participation in the CCGA.

Jennelle C. Hodge, PhD, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; Acting Editor-in-Chief CCGA, Associate Editor [AML Section]
Fabiola-Quintero-Rivera, MD, Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles; Associate Editor CCGA [MDS/MPN Section]
Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; Co-Associate Editor CCGA [Lymphoma Section]


Picture coming soon:
Greg Corboy, PhD
LabPlus Auckland City Hospital (Auckland, New Zealand)
School of Clinical Sciences, Monash University (Melbourne, Australia)
Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia)
Co-Associate Editor CCGA [Lymphoma Section]